The Spatial Biology for Immuno-Oncology Summit is the definitive platform to attract the attention of top decision-makers in pharma. 

Over the past year, the immuno-oncology field has experienced an unprecedented surge in spatial transcriptomics innovations. Major players are investing heavily, leveraging spatial biology for enhanced cancer diagnostics and expanding their services, offering deep molecular profiling and custom data analytics. Strategic partnerships with leading spatial biology platform providers are increasing. 

 As we gather to answer crucial questions about the future of this space, your sponsorship ensures you’re at the forefront of this transformative wave, connecting with emerging technology companies, and securing a pivotal role in shaping the industry’s future. 

Why Partner:

partner image 1

Position Yourself as an Industry Expert

With the constant emergence of new spatial technology companies and, followed by interest from large pharma and investors, this meeting is a dedicated platform to put your independent expertise in front of the key decision-makers in the field

partner image 2

Meet & Network with Industry Peers

This meeting is full of decision-makers looking to see how they can improve user experience and streamline clinical trials - meet prospective clients during speed networking breaks, 1-2-1 meetings, and more informal networking opportunities

partner image 3

Generate Commercial Collaborations

Meet with C-Level execs, VPs, and Directors from leading pharma organizations attending this event with the mindset to evaluate new solutions and ideas. Start those conversations that could become your next long-term partnership

Experts Need Your Help With:

AI-powered Pathology

Biomarker Platforms

Imaging Companies

Data Analysis

Spatial Profiling

Assay Development

Who will you meet?

Graph 1
Graph 2